Radboudumc performs their first QuiremSpheres™ treatment

We are pleased to announce that the Radboudumc in Nijmegen has treated its first patient with QuiremSpheres. This milestone has been made possible by an interdisciplinary team, consisting of Dr. Marcel Janssen (Nuclear Medicine physician), Dr. Mark Arntz (Interventional Radiologist), as well  other hospital staff and technicians. The patient suffering from mCRC underwent a successful selective internal radiation therapy (SIRT) procedure. Quirem Medical and the Radboudumc collaborate closely in a number of research areas with the aim to fully exploit the unique imaging capabilities that QuiremSpheres provide to improve the perspective for liver cancer patients. The state-of-the-art Medical Innovation and Technology expert Center (MITeC) at the Radboudumc plays a central role in this collaboration. As of May 2018, the Radboud Translational Medicine (RTM) is fully operational for performing the final steps in the manufacturing process of QuiremSpheres.

Share this post

Necessary cookies help make a website more usable by enabling basic functions such as page navigation and access to secure areas of the website. The website cannot function properly without these cookies.

Enable

Statistical cookies help us understand how visitors use the website by collecting and reporting data anonymously. These cookies therefore do not collect any personal data from visitors.

Cookies are small text files that can be used by websites to make user experiences more efficient. By law, we may store cookies on your device if they are strictly necessary for the use of the website. These are the functional cookies. We need your consent for all other types of cookies. These cookies are named as: preferences and statistics and you do not have to accept them. This website uses different types of cookies. Some cookies are placed by third party services that are displayed on our pages.

This website uses cookies to improve your experience. You can manage your options here.